calmidazolium has been researched along with Akinetic-Rigid Variant of Huntington Disease in 2 studies
calmidazolium: powerful inhibitor of or red blood cell Ca++-ATPase & Ca++ transport into inside-out red blood cell vesicles; RN refers to chloride; structure in first source; an antagonist of calmodulin
calmidazolium : An imidazolium ion that is imidazolium cation substituted by a bis(4-chlorophenyl)methyl group at position 1 and a 2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl group at position 3. It acts as an antagonist of calmodulin, a calcium binding messenger protein.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, V | 1 |
| Deepak, RNVK | 1 |
| Sengupta, B | 1 |
| Joshi, AS | 1 |
| Fan, H | 1 |
| Sen, P | 1 |
| Thakur, AK | 1 |
| Piggott, MA | 1 |
| Candy, JM | 1 |
| Perry, RH | 1 |
2 other studies available for calmidazolium and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Calmidazolium Chloride and Its Complex with Serum Albumin Prevent Huntingtin Exon1 Aggregation.
Topics: Animals; Biological Assay; Cell Line; Huntingtin Protein; Huntington Disease; Imidazoles; Mice; Mole | 2018 |
[3H]nitrendipine binding in temporal cortex in Alzheimer's and Huntington's diseases.
Topics: Aged; Alzheimer Disease; Binding, Competitive; Calcium; Calcium Channel Blockers; Calcium Channels; | 1991 |